Intellectual Property India Publishes Patent Application for “bicyclic Heteroaryl Derivatives As Ectonucleotide Pyrophosphatase Phosphodiesterase 1 Inhibitors”

Posted On: 2026-07-13 Patentwipo

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202618074643 A) filed by Riboscience LLC on June 16, 2026, for “bicyclic Heteroaryl Derivatives As Ectonucleotide Pyrophosphatase Phosphodiesterase 1 Inhibitors”.

Inventors include Hawley, Ronald; and Klumpp, Klaus.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: The present disclosure provides certain bicyclic heteroaryl compounds that inhibit ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) enzymatic activity and are therefore useful for the treatment of diseases and conditions modulated at least in part by ENPP1. In some embodiments, the bicyclic heteroaryl compounds includes those of Formula (I). Also provided herein are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

Disclaimer: Curated by HT Syndication.

Category

Intellectual Property India Publishes Patent Application for “bicyclic Heteroaryl Derivatives As Ectonucleotide Pyrophosphatase Phosphodiesterase 1 Inhibitors”